![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_8716d1379fc9fcdaef8beabc3dd79da1.svg) | N-[[5-[1-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]benzamide | IC50 | 21000.0 [1], 100000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_f51b049765c4fb65e756372294890310.svg) | N-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3-(trifluoromethoxy)benzamide | IC50 | 2550.0 [1], 8540.0 [2], 15300.0 [3] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_1a916b499f81cc02e6eac8952a0b9b9b.svg) | 6-(4-(Trifluoromethoxy)phenyl)-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridine | IC50 | 400.0 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_25d9b33026565fc9b2cb6059f4773987.svg) | 2,2-Diphenyl-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]acetamide | IC50 | 20.0 [1], 32.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_25b86e6872de5faf9c66524e9a51a6ca.svg) | 2-[(3-Methyl-1,2,4-oxadiazol-5-yl)methyl]-6-[4-(trifluoromethoxy)phenyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one | IC50 | 4800.0 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_71450bda5f550ba3db0463b13d3782d9.svg) | Tetrodotoxin | IC50 | 30.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_a9ffb2cd819dd23e2ccc53b53ac3a5f8.svg) | Mexiletine hydrochloride | IC50 | 11000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_a62cbe90f5af57b0f55ccaee19647f69.svg) | Senicapoc | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_55892479c77cb8cbec69941708da1cce.svg) | CID 46840946 | IC50 | 677.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_bc986a7b60cc6144da736fe13960b480.svg) | Eleclazine | IC50 | 3400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_29c7c51dd7c16d8e9004503d08bade20.svg) | 6-Amino-N-methyl-5-(2,3,5-trichlorophenyl)picolinamide | IC50 | 13000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_0655a0f80832be04b0950c13a7240f1c.svg) | 1-[2-Methoxy-4-[3-(trifluoromethyl)phenyl]phenyl]-2-oxo-N-pyrimidin-2-ylquinoline-6-sulfonamide | IC50 | 42500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_c81436d3cbf1c35466eedc3219b90925.svg) | CID 91666633 | IC50 | 45.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_42e8e96aab4c8e3ece5dee1b2eaa9ac5.svg) | 4-[4-Chloro-2-[2-(1-ethylazetidin-3-yl)pyrazol-3-yl]phenoxy]-3-cyano-N-(1,3-thiazol-4-yl)benzenesulfonamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_526071f5d6a907983935b8ce39e33166.svg) | 5-Chloro-2-fluoro-4-[2-pyridazin-4-yl-4-(trifluoromethyl)phenoxy]-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide | IC50 | 8750.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_109a9052a4f3704cfeb82e7ab56f50a0.svg) | 2-(4-(4-(Trifluoromethoxy)phenyl)-1H-imidazol-2-yl)propan-2-amine | IC50 | 11000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_de119abfff9f20abb9a096724bb462f5.svg) | 4-[2-(2-Amino-3H-benzimidazol-5-yl)-4-chlorophenoxy]-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | IC50 | 6380.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_c845d6dbbed4ea254b11f7c86ac18aaa.svg) | 4-[2-(3-Amino-1,2-benzoxazol-5-yl)-4-chlorophenoxy]-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | IC50 | 3080.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_da41649d64ca27df34964228f23b8832.svg) | 4-[4-Chloro-2-(2-methylpyrazol-3-yl)phenoxy]-3-fluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | IC50 | 216.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_6062e2101bd51941236f348cea3c774a.svg) | 4-[4-Chloro-2-(2-methylpyrazol-3-yl)phenoxy]-3-cyano-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | IC50 | 3000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_8889ba945b627a40a411d2b142f7e056.svg) | 4-[2-Methoxy-4-(trifluoromethyl)phenyl]-N-(1,3-thiazol-2-yl)quinazoline-7-sulfonamide | IC50 | 7300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_515329b7db7a38bb7fca2539a3ba01ac.svg) | N-[6-Cyclopropyl-7-[(3,5-dichlorophenoxy)methyl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]methanesulfonamide | IC50 | 112.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_ba3d0dbddcb0669e9014f069801a24f3.svg) | 3-Cyano-4-[2-[2-[(2-piperidin-4-ylethylamino)methyl]pyridin-4-yl]-4-[3-(trifluoromethyl)phenyl]phenoxy]-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | IC50 | 309.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_f867a3109129b1ce591f7eb629418ce7.svg) | 1-[5-Fluoro-2-methoxy-4-[3-(trifluoromethyl)phenyl]phenyl]-N-(1,2-oxazol-3-yl)isoquinoline-6-sulfonamide | IC50 | 17000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_15263a6fa3818afc9728678451f21a5f.svg) | 2-[1-[2-Hydroxy-3-[3-(trifluoromethyl)phenoxy]propyl]piperidin-4-yl]-3H-isoindol-1-one | IC50 | 1200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_3612ae97b47306be9ee01e5998a5123e.svg) | 2-[1-[2-Hydroxy-3-[4-(trifluoromethyl)phenoxy]propyl]piperidin-4-yl]-3H-isoindol-1-one | IC50 | 1800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_6364e7a7d246c45f0d782028428726ee.svg) | 2-[1-[2-Hydroxy-3-[2-methoxy-4-(trifluoromethyl)phenoxy]propyl]piperidin-4-yl]-3H-isoindol-1-one | IC50 | 910.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_00cb85dd4aab88a15764b118831f9635.svg) | 2-[1-[2-Hydroxy-3-[[4-(trifluoromethyl)phenyl]methoxy]propyl]piperidin-4-yl]-3H-isoindol-1-one | IC50 | 3000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_9ea67b60ef221d1f7c1b425d7d981e4d.svg) | N-[1-[2-Hydroxy-3-[4-(trifluoromethyl)phenoxy]propyl]piperidin-4-yl]benzamide | IC50 | 800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_002af3a514ec19d51c9f2d9665dcadcc.svg) | 1-[2-Hydroxy-3-[4-(trifluoromethyl)phenoxy]propyl]-N-phenylpiperidine-4-carboxamide | IC50 | 3100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_87c950caf3d91a8d996e0a12d08a6515.svg) | 1-[2-Hydroxy-3-[[2-methoxy-4-(trifluoromethyl)phenyl]methoxy]propyl]-N-phenylpiperidine-4-carboxamide | IC50 | 3300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_337d3994738292f180c6595c29ae4e69.svg) | 8-[4-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]piperazin-1-yl]-4H-1,4-benzoxazin-3-one | IC50 | 33000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_400ea2d89165ff91e0d72f7083258aa0.svg) | 8-[1-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]piperidin-4-yl]-4H-1,4-benzoxazin-3-one | IC50 | 4400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_65c0d2e5af26de4d7234bccfc0dbbb4b.svg) | 5-[4-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]piperazin-1-yl]-3,4-dihydro-1H-quinolin-2-one | IC50 | 21000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_4aa072911fa77be1694d527d7bb96ebd.svg) | 5-[1-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]piperidin-4-yl]-3,4-dihydro-1H-quinolin-2-one | IC50 | 7100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_1e790d1a5d314e8e5b9f0d8d4e1bc90c.svg) | 7-[4-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]piperazin-1-yl]-3H-1,3-benzoxazol-2-one | IC50 | 33000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_0b1c867d3354707e703359c3959a82eb.svg) | 4-[1-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]piperidin-4-yl]-1,4-benzoxazin-3-one | IC50 | 4800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_a5e278ea2326c68284eb550feac82921.svg) | 3-[1-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]piperidin-4-yl]-1,3-benzoxazol-2-one | IC50 | 5400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_fa237d6061618540382b1174b3695214.svg) | 1-[1-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]piperidin-4-yl]-3H-indol-2-one | IC50 | 26000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_7476a0400cc4430eb7b558de38509532.svg) | 2-[1-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]piperidin-4-yl]-3H-isoindol-1-one | IC50 | 3300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_c5beb203769b7de411e55824f9c99a5f.svg) | N-[1-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]piperidin-4-yl]benzamide | IC50 | 3200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_4078373d9e4fa3b03ee71376c10b3047.svg) | 1-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]-N-phenylpiperidine-4-carboxamide | IC50 | 4300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_803dd369023f76442011879aabbbea0b.svg) | 2-[1-[3-(3-Benzoylphenoxy)-2-hydroxypropyl]piperidin-4-yl]-3H-isoindol-1-one | IC50 | 920.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_615ba5132b774efab4ba2e7765a00179.svg) | 2-[1-[3-(4-Benzoylphenoxy)-2-hydroxypropyl]piperidin-4-yl]-3H-isoindol-1-one | IC50 | 670.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_748de4d46de0a0644d065f8d999e314f.svg) | 2-[1-(2-Hydroxy-3-phenoxypropyl)piperidin-4-yl]-3H-isoindol-1-one | IC50 | 8000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_e08e6d877fcdfcb84cebd6f3eecdd21a.svg) | 2-[1-[2-Hydroxy-3-(2-methoxyphenoxy)propyl]piperidin-4-yl]-3H-isoindol-1-one | IC50 | 19000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_a94edc250bf1062d1bdb9bc62c23fa6b.svg) | 2-[1-[2-Hydroxy-3-(3-methoxyphenoxy)propyl]piperidin-4-yl]-3H-isoindol-1-one | IC50 | 3000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_6b05ce731009669cd8961f3edea35fcf.svg) | 2-[1-[2-Hydroxy-3-(4-methoxyphenoxy)propyl]piperidin-4-yl]-3H-isoindol-1-one | IC50 | 2700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_3ab0e6294977aa7f6cb0f9b76d72a8c2.svg) | 2-[1-[2-Hydroxy-3-[2-(trifluoromethyl)phenoxy]propyl]piperidin-4-yl]-3H-isoindol-1-one | IC50 | 4500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_1136b1e4e8f9e00267303ea17f253ea9.svg) | 1H-Pyrazole-5-carboxamide, N-(6-amino-5-(2-chloro-5-methoxyphenyl)-2-pyridinyl)-1-methyl- | IC50 | 37000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_30988ce47fc7781cfc2186f4cc15faa0.svg) | N-[7-(1-Adamantylmethoxy)-6-cyclopropyl-[1,2,4]triazolo[4,3-a]pyridin-3-yl]methanesulfonamide | IC50 | 53.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_0aa4b8d61a168769586ec9f0aa309823.svg) | 2-[1-[2-Hydroxy-3-[[2-methoxy-4-(trifluoromethyl)phenyl]methoxy]propyl]piperidin-4-yl]-3H-isoindol-1-one | IC50 | 1500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_cb1fa0e8a82eb69a0157fff62921b63e.svg) | 4-[[3-Chloro-4-(trifluoromethoxy)phenyl]methoxy]-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | IC50 | 455.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_8846e54044f2acbebb0b9e49bcb8c2b2.svg) | N-[[3-Chloro-4-(trifluoromethoxy)phenyl]methyl]-3-fluoro-4-(1,2,4-thiadiazol-5-ylsulfamoyl)benzamide | IC50 | 12.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_f048aaa9685278fd01dc1f2f4b97d5dc.svg) | N-[[3-Chloro-4-(trifluoromethoxy)phenyl]methyl]-3-fluoro-4-(1,3-thiazol-2-ylsulfamoyl)benzamide | IC50 | 20.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-i-alpha-subunit_7ac9b521c3da8cda7f541edca30c052d.svg) | 3-[[5-[4-(Trifluoromethoxy)phenyl]-1H-imidazol-2-yl]methyl]oxetan-3-amine | IC50 | 43000.0 [1] |